Enhanced Detection of Druggable Mutations in Non–Small Cell Lung Cancer Using Targeted Collection of Bronchial Washing Fluid Compared With Plasma and Tumor Tissue Ninety-nine patients with resectable ...

The process of staging lung cancer accurately plays a major role in establishing treatment options and predicting survival. Proper lung cancer staging demands a thorough understanding of TNM-8, which ...

At AACR 2026, researchers presented Path-IO, an AI-driven pathomics model that predicts which metastatic non-small cell lung cancer patients will benefit from immunotherapy. Validated across global ...

Effect of novel polygenetic variant of HUNT lung cancer model on lung cancer risk assessment over clinical model among light smokers (average 9 pack-years). This is an ASCO Meeting Abstract from the ...

Doctors typically divide small cell lung cancer (SCLC) into limited or extensive stages, depending on whether the cancer is in one lung, both lungs, or has spread to distant areas. Staging for small ...

The likelihood of EGFR-positive lung cancer returning is largely tied to how advanced it is when first diagnosed, with lower chances in early stages and higher odds in later stages. Newer targeted ...

Lung adenocarcinoma is the most common type of lung cancer diagnosed in the U.S. Just over half of all non-small-cell lung cancers (NSCLCs) are adenocarcinomas. Finding out that you're at risk of lung ...

The University of Kentucky Markey Cancer Center's Graham Warren, M.D., Ph.D., and international collaborators have led a groundbreaking study that could change the way lung cancer is diagnosed and ...

Three-fourths of patients had cancer-free mediastinal lymph nodes, clear surgical margins ...